Literature DB >> 27372390

The first point prevalence survey of health care-associated infection and antimicrobial use in a Japanese university hospital: A pilot study.

Hiroshi Morioka1, Aki Hirabayashi1, Mitsutaka Iguchi1, Yuka Tomita1, Daizo Kato1, Naokazu Sato2, Miyuki Hyodo3, Naoko Kawamura3, Takuya Sadomoto3, Kazuya Ichikawa4, Takayuki Inagaki4, Yoshiaki Kato4, Yuichi Kouyama4, Yoshinori Ito5, Tetsuya Yagi6.   

Abstract

BACKGROUND: Point prevalence surveys (PPSs) in Japanese hospitals have not yet been reported. The purpose of this pilot PPS study was to evaluate the epidemiology of health care-associated infections (HAIs) and antimicrobial use in a Japanese tertiary university hospital.
METHODS: A 1-day, cross-sectional PPS was performed at a Japanese university hospital. Data on demographics, active HAIs, and antimicrobial use of all inpatients were collected using a data collection form.
RESULTS: Of 841 patients, 85 (10.1%) had 90 active HAIs, and 308 patients (36.6%) were administered 494 antimicrobials. Among the 90 HAIs and 58 pathogens, the most frequent infection and isolated pathogen were pneumonia (20.0%) and Enterobacteriaceae (27.6%), respectively. Of the 118 antimicrobials used for treatment of HAIs, carbapenems were the most frequently administered category of antimicrobials (22.9%). In regard to antimicrobials for surgical prophylaxis, 37 of 119 (31.1%) were administered to patients on postoperative day 3 or later, and 48 of 119 (40.3%) were administered orally.
CONCLUSIONS: The incidence of HAIs is higher than in other developed countries. The social and medical situation in Japan may affect patient demographics, active HAIs, and antimicrobial use. Multicenter PPSs are necessary to uncover the real epidemiology of HAIs and antimicrobial use in Japan.
Copyright © 2016 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Point prevalence survey; antimicrobial use; health care–associated infection; hospital epidemiology

Mesh:

Substances:

Year:  2016        PMID: 27372390     DOI: 10.1016/j.ajic.2016.03.045

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  9 in total

1.  Point prevalence surveys of health-care-associated infections: a systematic review.

Authors:  Zikria Saleem; Brian Godman; Mohamed Azmi Hassali; Furqan Khurshid Hashmi; Faiza Azhar; Inayat Ur Rehman
Journal:  Pathog Glob Health       Date:  2019-06-19       Impact factor: 2.894

2.  Establishing the prevalence of healthcare-associated infections in Australian hospitals: protocol for the Comprehensive Healthcare Associated Infection National Surveillance (CHAINS) study.

Authors:  Philip L Russo; Andrew Stewardson; Allen C Cheng; Tracey Bucknall; Kalisvar Marimuthu; Brett G Mitchell
Journal:  BMJ Open       Date:  2018-11-08       Impact factor: 2.692

3.  The prevalence of healthcare associated infections among adult inpatients at nineteen large Australian acute-care public hospitals: a point prevalence survey.

Authors:  Philip L Russo; Andrew J Stewardson; Allen C Cheng; Tracey Bucknall; Brett G Mitchell
Journal:  Antimicrob Resist Infect Control       Date:  2019-07-15       Impact factor: 4.887

4.  Prevalence of antimicrobial use and active healthcare-associated infections in acute care hospitals: a multicentre prevalence survey in Japan.

Authors:  Junpei Komagamine; Taku Yabuki; Masaki Kobayashi; Taro Okabe
Journal:  BMJ Open       Date:  2019-06-28       Impact factor: 2.692

5.  A trend in prevalence of antimicrobial use and appropriateness of antimicrobial therapy in an acute care hospital from 2018 to 2019: repeated prevalence surveys in Japan.

Authors:  Junpei Komagamine; Taku Yabuki; Taku Hiraiwa
Journal:  BMC Res Notes       Date:  2019-12-18

6.  Antimicrobial Usage and Resistance in Makkah Region Hospitals: A Regional Point Prevalence Survey of Public Hospitals.

Authors:  Abdul Haseeb; Hani Saleh Faidah; Manal Algethamy; Saleh Alghamdi; Ghaidaa Ali Alhazmi; Afnan Owedah Alshomrani; Bashair Rjyan Alqethami; Hind Saeed Alotibi; Maali Zayed Almutiri; Khawlah Saad Almuqati; Amjad Abdullah Albishi; Mahmoud Essam Elrggal; Ahmad Jamal Mahrous; Asim Abdulaziz Khogeer; Zikria Saleem; Muhammad Shahid Iqbal; Aziz Sheikh
Journal:  Int J Environ Res Public Health       Date:  2021-12-27       Impact factor: 3.390

7.  Five-year point prevalence survey of healthcare-associated infections and antimicrobial use in a Japanese university hospital.

Authors:  H Morioka; M Iguchi; N Tetsuka; F Kinoshita; Y Tomita; D Kato; A Hirabayashi; A Matsumoto; K Oka; H Kato; T Inagaki; Y Kato; K Kitagawa; K Ichikawa; Y Kouyama; N Kawamura; Y Toyodome; N Adachi; Y Ito; T Yagi
Journal:  Infect Prev Pract       Date:  2021-06-04

8.  A nationwide assessment of the burden of healthcare-associated infections and antimicrobial use among surgical patients: results from Serbian point prevalence survey, 2017.

Authors:  Vesna Šuljagić; Milica Bajčetić; Vesna Mioljević; Gorana Dragovac; Biljana Mijović; Ivana Janićijević; Zorana Đorđević; Gordana Krtinić; Violeta Rakić; Ivana Ćirković; Vladimir Nikolić; Ljiljana Marković-Denić
Journal:  Antimicrob Resist Infect Control       Date:  2021-03-06       Impact factor: 4.887

9.  Analysis of Continuous Prevalence Survey of Healthcare-Associated Infections Based on the Real-Time Monitoring System in 2018 in Shandong in China.

Authors:  Jian Sun; Wen Qin; Lei Jia; Zhen Sun; Hua Xu; Yiyi Hui; Anman Gu; Weiguang Li
Journal:  Biomed Res Int       Date:  2021-06-11       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.